Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 582.00
-19.00 (-3.16%)
Jun 3, 2026, 3:10 PM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 24.41 billion as of June 2, 2026. Its market cap has decreased by -4.60% in one year.
Market Cap
24.41B
Enterprise Value
21.16B
Revenue
2.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
582.00
Market Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 24.41B, an increase of 307.30%. That is a compound annual growth rate of 7.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 24.41B | -3.38% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healios K.K. | 44.01B |
| Cuorips | 37.65B |
| AnGes | 19.02B |
| Renascience | 18.05B |
| StemRIM | 17.93B |
| RaQualia Pharma | 13.04B |
| ReproCELL | 12.16B |
| Stella Pharma | 11.88B |